About PharmAthene
PharmAthene is a company based in Annapolis (United States) founded in 2001.. PharmAthene has raised $50 million across 3 funding rounds. The company has 15 employees as of December 31, 2016. PharmAthene has completed 1 acquisition, including Altimmune. PharmAthene operates in a competitive market with competitors including HOOKIPA Pharma, Insmed, Stallergenes Greer, Valneva and Affinivax, among others.
- Headquarter Annapolis, United States
- Employees 15 as on 31 Dec, 2016
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pharmathene Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$50 M (USD)
in 3 rounds
-
Latest Funding Round
$9.9 M (USD), Post-IPO
Nov 18, 2010
-
Investors
-
Employee Count
15
as on Dec 31, 2016
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PharmAthene
PharmAthene has successfully raised a total of $50M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $9.9 million completed in November 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $9.9M
-
First Round
First Round
(12 Oct 2004)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2010 | Amount | Post-IPO - PharmAthene | Valuation |
investors |
|
| Aug, 2009 | Amount | Post-IPO - PharmAthene | Valuation |
investors |
|
| Oct, 2004 | Amount | Series B - PharmAthene | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by PharmAthene
PharmAthene has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Altimmune. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Vaccines for infectious diseases and solid tumors are developed.
|
1997 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - PharmAthene
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pharmathene Comparisons
Competitors of PharmAthene
PharmAthene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HOOKIPA Pharma, Insmed, Stallergenes Greer, Valneva and Affinivax, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| domain | founded_year | HQ Location |
Developer of small molecule inhibitors for rare lung diseases
|
|
| domain | founded_year | HQ Location |
Allergen immunotherapies for respiratory allergies are developed.
|
|
| domain | founded_year | HQ Location |
Prophylactic vaccines for infectious diseases are developed and advanced.
|
|
| domain | founded_year | HQ Location |
Technology-based conjugate vaccines against infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
In vivo gene editing technology is developed for microbiome modulation.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pharmathene
Frequently Asked Questions about PharmAthene
When was PharmAthene founded?
PharmAthene was founded in 2001 and raised its 1st funding round 3 years after it was founded.
Where is PharmAthene located?
PharmAthene is headquartered in Annapolis, United States. It is registered at Annapolis, Maryland, United States.
Who is the current CEO of PharmAthene?
Vipin K Garg is the current CEO of PharmAthene.
Is PharmAthene a funded company?
PharmAthene is a funded company, having raised a total of $50M across 3 funding rounds to date. The company's 1st funding round was a Series B of $50M, raised on Oct 12, 2004.
How many employees does PharmAthene have?
As of Dec 31, 2016, the latest employee count at PharmAthene is 15.
What does PharmAthene do?
PharmAthene is a biopharma company that focuses on defensive countermeasures against biological and chemical warfare. The company is in beginning animal studies on its next generation anthrax vaccine based on its proprietary vaccine development platform, and hopes to file for FDA approvals for human trials in 2017. Additionally, the company has also entered into an agreement with ImmunoVaccine Technologies for the exclusive use of its DepoVaxTM vaccine platform to develop an anthrax vaccine utilizing its Recombinant Protective Antigen system.
Who are the top competitors of PharmAthene?
PharmAthene's top competitors include HOOKIPA Pharma, Stallergenes Greer and Valneva.
How many acquisitions has PharmAthene made?
PharmAthene has made 1 acquisition, including Altimmune.